In the following video, Motley Fool health-care analyst David Williamson takes a question from a Fool reader, who asks, "Should I buy, sell or hold Teva Pharmaceutical Industries Limited (TEVA 0.09%)?"
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Ask a Fool: Buy, Sell or Hold Teva?
By Dave Williamson
–
Jun 27, 2013 at 5:43PM
NYSE: TEVA
Teva Pharmaceutical Industries
Market Cap
$19B
Today's Change
(0.09%) $0.01
Current Price
$16.96
Price as of June 23, 2025, 3:58 p.m. ET
Is Teva too dangerous to buy right now?
David Williamson has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
Teva Pharmaceutical Industries
TEVA
$16.96
(0.09%)
$0.01
Allergan
AGN
Biogen
BIIB
$124.76
(-1.80%)
$-2.28
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
Why Teva Pharmaceutical Stock Is Soaring Today
Why Teva Pharmaceutical Stock Is Sinking Today
Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript
My Top 10 Portfolio Holdings for 2025
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.